Skip to main content
News

Intrexon Corporation – Synthetic Biology through Better DNA – Investor Relations – Newsroom

By January 10, 2014No Comments
intrexon-logo

intrexon-logo

Intrexon Corporation (NYSE: XON), a leader in synthetic biology, announced today that it has entered into a research and development collaboration with Johnson & Johnson Innovation and its affiliate Johnson & Johnson Consumer & Personal Products Worldwide, a division of Johnson & Johnson Consumer Companies, Inc., to advance new skin and hair care products.

“We look forward to advancing new skin and hair beauty products that have measurable impact for consumers,” said Randal J. Kirk, Chairman and Chief Executive Officer, Intrexon.  “By combining Intrexon’s synthetic biology approaches with the capabilities at Johnson & Johnson Innovation and Johnson & Johnson Consumer & Personal Products Worldwide, we believe that there are multiple areas for new product exploration.”

{iframe}http://investors.dna.com/phoenix.zhtml?c=249599&p=irol-newsArticle&ID=1887155&highlight={/iframe}

Leave a Reply

You have successfully subscribed to the newsletter

There was an error while trying to send your request. Please try again.

BioHealth Innovation will use the information you provide on this form to be in touch with you and to provide updates and marketing.